Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
FLAC was delisted on the 22nd of November, 2022.
48 hedge funds and large institutions have $78.9M invested in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
14% more funds holding
Funds holding: 42 → 48 (+6)
14% more capital invested
Capital invested by funds: $69.5M → $78.9M (+$9.43M)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$4.41M |
| 2 |
D.E. Shaw & Co
New York
|
+$4M |
| 3 |
SCM
Saba Capital Management
New York
|
+$2.4M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.48M |
| 5 |
GCL
Glazer Capital LLC
New York
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ESCM
Echo Street Capital Management
New York
|
-$3.04M |
| 2 |
AC
Athanor Capital
New York
|
-$2M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.24M |
| 4 |
VCM
Vivaldi Capital Management
Chicago,
Illinois
|
-$123K |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$66.6K |
FLAC Hedge Fund Activity: Q4 2021 in Review
48 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) for Q4 2021, worth a combined $78.9M — up 14% from $69.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new FLAC positions and 4 closed out — a net gain of 6 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Ensign Peak Advisors, opening a new position worth an estimated $4.41M. The largest seller was Echo Street Capital Management, exiting entirely with an estimated $3.04M sold.
- 48 institutional investors held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) as of Q4 2021, up from 42 in Q3 2021.
- Funds reported $78.9M of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares stock for Q4 2021, up 14% quarter-over-quarter.
- 10 funds opened new Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares positions in Q4 2021 and 4 closed out, a net change of +6 holders.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares buyer in Q4 2021 was Ensign Peak Advisors, an estimated $4.41M added.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares seller in Q4 2021 was Echo Street Capital Management, an estimated $3.04M sold.
Based on aggregated 13F filings for Q4 2021.